-
公开(公告)号:PL197156B1
公开(公告)日:2008-03-31
申请号:PL33685798
申请日:1998-05-14
Applicant: SERVIER LAB
Inventor: GUILLAUMET GERALD , VIAUD MARIE-CLAUDE , MAMAI AHMED , CHARTON ISABELLE , RENARD PIERRE , BENNEJEAN CAROLINE , GUARDIOLA BEATRICE , DAUBOS PHILIPPE
IPC: C07D311/58 , A61K31/335 , A61K31/35 , A61K31/352 , A61K31/353 , A61K31/357 , A61K31/382 , A61K31/385 , A61K31/39 , A61P3/04 , A61P3/10 , A61P9/00 , A61P9/06 , A61P9/12 , A61P15/00 , A61P25/00 , A61P25/04 , A61P25/16 , A61P25/18 , A61P25/20 , A61P25/22 , A61P25/28 , A61P35/00 , A61P43/00 , C07D311/60 , C07D311/80 , C07D311/92 , C07D319/20 , C07D327/06 , C07D335/06 , C07D339/08 , C07D493/04
-
公开(公告)号:NO317991B1
公开(公告)日:2005-01-17
申请号:NO20006128
申请日:2000-12-01
Applicant: SERVIER LAB
Inventor: GUILLAUMET GERALD , DELAGRANGE PHILIPPE , BENNEJEAN CAROLINE , RENARD PIERRE , VIAUD MARIE-CLAUDE , DAUBOS PHILIPPE
IPC: A61K31/538 , A61K31/5415 , A61P1/00 , A61P1/14 , A61P3/04 , A61P3/10 , A61P9/00 , A61P9/10 , A61P25/00 , A61P25/04 , A61P25/06 , A61P25/08 , A61P25/16 , A61P25/18 , A61P25/20 , A61P25/22 , A61P25/24 , A61P25/28 , A61P43/00 , C07D265/36 , C07D279/16 , C07D413/06 , C07D413/12 , A61K31/541 , A61K31/536
Abstract: 1,4-Benzoxazine and 1,4-benzothiazine compounds (I) and their acid or base addition salts, enantiomers and diastereomers, are new. 1,4-Benzoxazine and 1,4-benzothiazine compounds of formula (I) and their acid or base addition salts, enantiomers and diastereomers, are new. R1 = R, OR, SR, SO2NRR', NRR', -N(R)C(=Z)R', -N(R)SO2R', -N(R)C(=Z)OR', -N(R)C(=Z)NR'R'', C(=Z)OR, -OC(=Z)R or -C(=Z)NRR'; Z = S or O; R, R', R'' = H or 1-6C alkyl, 2-6C alkenyl, 2-6C alkynyl, 3-8C cycloalkyl or 3-8C cycloalkyl-1-6C alkyl (all optionally substituted by one or more B), or aryl, aryl-1-6C alkyl, heteroaryl or heteroaryl-1-6C alkyl (all optionally substituted by one or more D; or NRR' or NR'R'' = morpholinyl, piperidinyl, piperazinyl or pyrrolidinyl; G = 1-4C alkylene (optionally substituted by R, OR, COR or COOR; A = -C(=Z)NRR', -N(R)C(=Z)R' or -N(R)C(=Z)NR'R''; R2 = halo, R, OR, COR, COOR or OCOR; X = O or S; dotted line = single or double bond; B = OH, alkoxy, alkyl, polyhaloalkyl, NH2, NH(1-6C alkyl), N(1-6C alkyl)2 or halo; D = OH, alkoxy, amino, alkylamino, dialkylamino, nitro, cyano, polyhaloalkyl, formyl, carboxyl, alkoxycarbonyl, amido or halo; aryl = phenyl, naphthyl or biphenyl; and heteroaryl = mono- or bicyclic aromatic group containing 1-3 O, S or N; provided that when A = -C(=Z)NRR', G = 2-4C alkylene.
-
公开(公告)号:AU774186B2
公开(公告)日:2004-06-17
申请号:AU7207300
申请日:2000-12-06
Applicant: SERVIER LAB
Inventor: VIAUD MARIE-CLAUDE , GUILLAUMET GERALD , DAUBOS PHILIPPE , BENNEJEAN CAROLINE , DELAGRANGE PHILIPPE , RENARD PIERRE
IPC: A61K31/538 , A61K31/5415 , A61P1/00 , A61P1/14 , A61P3/04 , A61P3/10 , A61P9/00 , A61P9/10 , A61P25/00 , A61P25/04 , A61P25/06 , A61P25/08 , A61P25/16 , A61P25/18 , A61P25/20 , A61P25/22 , A61P25/24 , A61P25/28 , A61P43/00 , C07D265/36 , C07D279/16 , C07D413/06 , C07D413/12 , A61K31/535
Abstract: 1,4-Benzoxazine and 1,4-benzothiazine compounds (I) and their acid or base addition salts, enantiomers and diastereomers, are new. 1,4-Benzoxazine and 1,4-benzothiazine compounds of formula (I) and their acid or base addition salts, enantiomers and diastereomers, are new. R1 = R, OR, SR, SO2NRR', NRR', -N(R)C(=Z)R', -N(R)SO2R', -N(R)C(=Z)OR', -N(R)C(=Z)NR'R'', C(=Z)OR, -OC(=Z)R or -C(=Z)NRR'; Z = S or O; R, R', R'' = H or 1-6C alkyl, 2-6C alkenyl, 2-6C alkynyl, 3-8C cycloalkyl or 3-8C cycloalkyl-1-6C alkyl (all optionally substituted by one or more B), or aryl, aryl-1-6C alkyl, heteroaryl or heteroaryl-1-6C alkyl (all optionally substituted by one or more D; or NRR' or NR'R'' = morpholinyl, piperidinyl, piperazinyl or pyrrolidinyl; G = 1-4C alkylene (optionally substituted by R, OR, COR or COOR; A = -C(=Z)NRR', -N(R)C(=Z)R' or -N(R)C(=Z)NR'R''; R2 = halo, R, OR, COR, COOR or OCOR; X = O or S; dotted line = single or double bond; B = OH, alkoxy, alkyl, polyhaloalkyl, NH2, NH(1-6C alkyl), N(1-6C alkyl)2 or halo; D = OH, alkoxy, amino, alkylamino, dialkylamino, nitro, cyano, polyhaloalkyl, formyl, carboxyl, alkoxycarbonyl, amido or halo; aryl = phenyl, naphthyl or biphenyl; and heteroaryl = mono- or bicyclic aromatic group containing 1-3 O, S or N; provided that when A = -C(=Z)NRR', G = 2-4C alkylene.
-
公开(公告)号:DK0998471T3
公开(公告)日:2007-07-02
申请号:DK98925703
申请日:1998-05-14
Applicant: SERVIER LAB
Inventor: GUILLAUMET GERALD , VIAUD MARIE-CLAUDE , MAMAI AHMED , CHARTON ISABELLE , RENARD PIERRE , BENNEJEAN CAROLINE , GUARDIOLA BEATRICE , DAUBOS PHILIPPE
IPC: C07D311/58 , A61K31/335 , A61K31/35 , A61K31/352 , A61K31/353 , A61K31/357 , A61K31/38 , A61K31/382 , A61K31/385 , A61K31/39 , A61P3/04 , A61P3/10 , A61P9/06 , A61P9/12 , A61P15/00 , A61P25/00 , A61P25/04 , A61P25/16 , A61P25/18 , A61P25/20 , A61P25/22 , A61P25/28 , A61P35/00 , A61P43/00 , C07D311/60 , C07D311/80 , C07D311/92 , C07D319/20 , C07D327/06 , C07D335/06 , C07D339/08 , C07D493/04
Abstract: The invention relates to compounds of formula (I):wherein:R1, R2 and R3 are as defined in the description,X is as defined in the description,Y represents an oxygen atom, a sulphur atom, a C(H)q group, SO or SO2,n is equal to from 0 to 5,A represents a NR5R6 group,and medicinal products containing the same which are useful in treating or in preventing melatoninergic disorders.
-
公开(公告)号:AT233744T
公开(公告)日:2003-03-15
申请号:AT00403399
申请日:2000-12-05
Applicant: SERVIER LAB
Inventor: VIAUD MARIE-CLAUDE , GUILLAUMET GERALD , DAUBOS PHILIPPE , BENNEJEAN CAROLINE , DELAGRANGE PHILIPPE , RENARD PIERRE
IPC: A61K31/538 , A61K31/5415 , A61P1/00 , A61P1/14 , A61P3/04 , A61P3/10 , A61P9/00 , A61P9/10 , A61P25/00 , A61P25/04 , A61P25/06 , A61P25/08 , A61P25/16 , A61P25/18 , A61P25/20 , A61P25/22 , A61P25/24 , A61P25/28 , A61P43/00 , C07D265/36 , C07D279/16 , C07D413/06 , C07D413/12
Abstract: 1,4-Benzoxazine and 1,4-benzothiazine compounds (I) and their acid or base addition salts, enantiomers and diastereomers, are new. 1,4-Benzoxazine and 1,4-benzothiazine compounds of formula (I) and their acid or base addition salts, enantiomers and diastereomers, are new. R1 = R, OR, SR, SO2NRR', NRR', -N(R)C(=Z)R', -N(R)SO2R', -N(R)C(=Z)OR', -N(R)C(=Z)NR'R'', C(=Z)OR, -OC(=Z)R or -C(=Z)NRR'; Z = S or O; R, R', R'' = H or 1-6C alkyl, 2-6C alkenyl, 2-6C alkynyl, 3-8C cycloalkyl or 3-8C cycloalkyl-1-6C alkyl (all optionally substituted by one or more B), or aryl, aryl-1-6C alkyl, heteroaryl or heteroaryl-1-6C alkyl (all optionally substituted by one or more D; or NRR' or NR'R'' = morpholinyl, piperidinyl, piperazinyl or pyrrolidinyl; G = 1-4C alkylene (optionally substituted by R, OR, COR or COOR; A = -C(=Z)NRR', -N(R)C(=Z)R' or -N(R)C(=Z)NR'R''; R2 = halo, R, OR, COR, COOR or OCOR; X = O or S; dotted line = single or double bond; B = OH, alkoxy, alkyl, polyhaloalkyl, NH2, NH(1-6C alkyl), N(1-6C alkyl)2 or halo; D = OH, alkoxy, amino, alkylamino, dialkylamino, nitro, cyano, polyhaloalkyl, formyl, carboxyl, alkoxycarbonyl, amido or halo; aryl = phenyl, naphthyl or biphenyl; and heteroaryl = mono- or bicyclic aromatic group containing 1-3 O, S or N; provided that when A = -C(=Z)NRR', G = 2-4C alkylene.
-
6.
公开(公告)号:HU0003127A2
公开(公告)日:2002-05-29
申请号:HU0003127
申请日:1998-05-14
Applicant: SERVIER LAB
Inventor: BENNEJEAN CAROLINE , CHARTON ISABELLE , DAUBOS PHILIPPE , GUARDIOLA BEATRICE , GUILLAUMET GERALD , MAMAI AHMED , RENARD PIERRE , VIAUD MARIE-CLAUDE
IPC: A61K31/352 , A61K31/353 , A61K31/357 , A61K31/382 , A61K31/385 , A61K31/39 , A61P3/04 , A61P3/10 , A61P9/06 , A61P9/12 , A61P15/00 , A61P25/00 , A61P25/04 , A61P25/16 , A61P25/18 , A61P25/20 , A61P25/22 , A61P25/28 , A61P35/00 , A61P43/00 , C07D311/58 , C07D311/60 , C07D311/80 , C07D311/92 , C07D319/20 , C07D327/06 , C07D335/06 , C07D339/08 , C07D493/04
Abstract: The invention relates to compounds of formula (I):wherein:R1, R2 and R3 are as defined in the description,X is as defined in the description,Y represents an oxygen atom, a sulphur atom, a C(H)q group, SO or SO2,n is equal to from 0 to 5,A represents a NR5R6 group,and medicinal products containing the same which are useful in treating or in preventing melatoninergic disorders.
-
公开(公告)号:EA200001157A2
公开(公告)日:2001-06-25
申请号:EA200001157
申请日:2000-12-05
Applicant: SERVIER LAB
Inventor: VIAUD MARIE-CLAUDE , GUILLAUMET GERALD , DAUBOS PHILIPPE , BENNEJEAN CAROLINE , DELAGRANGE PHILIPPE , RENARD PIERRE
IPC: A61K31/538 , A61K31/5415 , A61P1/00 , A61P1/14 , A61P3/04 , A61P3/10 , A61P9/00 , A61P9/10 , A61P25/00 , A61P25/04 , A61P25/06 , A61P25/08 , A61P25/16 , A61P25/18 , A61P25/20 , A61P25/22 , A61P25/24 , A61P25/28 , A61P43/00 , C07D265/36 , C07D279/16 , C07D413/06 , C07D413/12
Abstract: Изобретениеотноситсяк соединениямформулы (I)где G представляеталкиленовуюцепь, содержащую 1-4-атомауглерода, A представляетгруппуX представляетатомкислородаилиатомсерыи Rи Rимеютзначения, указанныев описании. Изобретениетакжеотноситсяк лечебнымсредствам.
-
8.
公开(公告)号:PT998471E
公开(公告)日:2007-06-05
申请号:PT98925703
申请日:1998-05-14
Applicant: SERVIER LAB
Inventor: RENARD PIERRE , VIAUD MARIE-CLAUDE , GUILLAUMET GERALD , GUARDIOLA-LEMAITRE BEATRICE , CHARTON ISABELLE , MAMAI AHMED , BENNEJEAN CAROLINE , DAUBOS PHILIPPE
IPC: C07D311/58 , A61K31/335 , A61K31/35 , A61K31/352 , A61K31/353 , A61K31/357 , A61K31/38 , A61K31/382 , A61K31/385 , A61K31/39 , A61P3/04 , A61P3/10 , A61P9/06 , A61P9/12 , A61P15/00 , A61P25/00 , A61P25/04 , A61P25/16 , A61P25/18 , A61P25/20 , A61P25/22 , A61P25/28 , A61P35/00 , A61P43/00 , C07D311/60 , C07D311/80 , C07D311/92 , C07D319/20 , C07D327/06 , C07D335/06 , C07D339/08 , C07D493/04
-
公开(公告)号:AT356814T
公开(公告)日:2007-04-15
申请号:AT98925703
申请日:1998-05-14
Applicant: SERVIER LAB
Inventor: GUILLAUMET GERALD , VIAUD MARIE-CLAUDE , MAMAI AHMED , CHARTON ISABELLE , RENARD PIERRE , BENNEJEAN CAROLINE , GUARDIOLA BEATRICE , DAUBOS PHILIPPE
IPC: A61K31/352 , A61K31/353 , A61K31/357 , A61K31/382 , A61K31/385 , A61K31/39 , A61P3/04 , A61P3/10 , A61P9/06 , A61P9/12 , A61P15/00 , A61P25/00 , A61P25/04 , A61P25/16 , A61P25/18 , A61P25/20 , A61P25/22 , A61P25/28 , A61P35/00 , A61P43/00 , C07D311/58 , C07D311/60 , C07D311/80 , C07D311/92 , C07D319/20 , C07D327/06 , C07D335/06 , C07D339/08 , C07D493/04 , A61K31/35
Abstract: The invention relates to compounds of formula (I):wherein:R1, R2 and R3 are as defined in the description,X is as defined in the description,Y represents an oxygen atom, a sulphur atom, a C(H)q group, SO or SO2,n is equal to from 0 to 5,A represents a NR5R6 group,and medicinal products containing the same which are useful in treating or in preventing melatoninergic disorders.
-
10.
公开(公告)号:EA004762B1
公开(公告)日:2004-08-26
申请号:EA200001157
申请日:2000-12-05
Applicant: SERVIER LAB
Inventor: VIAUD MARIE-CLAUDE , GUILLAUMET GERALD , DAUBOS PHILIPPE , BENNEJEAN CAROLINE , DELAGRANGE PHILIPPE , RENARD PIERRE
IPC: A61K31/538 , A61K31/5415 , A61P1/00 , A61P1/14 , A61P3/04 , A61P3/10 , A61P9/00 , A61P9/10 , A61P25/00 , A61P25/04 , A61P25/06 , A61P25/08 , A61P25/16 , A61P25/18 , A61P25/20 , A61P25/22 , A61P25/24 , A61P25/28 , A61P43/00 , C07D265/36 , C07D279/16 , C07D413/06 , C07D413/12
Abstract: Изобретениеотноситсяк соединениямформулы (I)где G представляеталкиленовуюцепь, содержащую 1-4-атомауглерода,АпредставляетгруппуX представляетатомкислородаилиатомсерыи Rи Rимеютзначения, указанныев описании. Изобретениетакжеотноситсяк лечебнымсредствам.
-
-
-
-
-
-
-
-
-